Federal Agencies Release Draft Guidance for Good Importer Practices

News
Article

ePT--the Electronic Newsletter of Pharmaceutical Technology

A draft guidance for industry titled "Good Importer Practices" has been released to provide importers guidance on the steps they can take to help ensure imported products comply with the relevant statues and regulations of the United States throughout a product's lifecycle.

Rockville, MD (Jan. 12)-A draft guidance for industry titled “Good Importer Practices” was released to advise importers about the steps they can take to ensure that imported products comply with the relevant statutes and regulations of the United States throughout a product’s life cycle. The document is a collaborative effort on the part of the US Departments of Health and Human Services, Agriculture, Commerce, Homeland Security, and Transportation as well as the US Consumer Product Safety Commission, the US Environmental Protection Agency, and the Office of the US Trade Representative.

The draft guidance recommends that importers identify and minimize risks associated with imported products according to four guiding principles:

  • Establishing a product-safety management program

  • Knowing the product and applicable US requirements

  • Verifying product and company compliance with US requirements throughout the supply chain and product life cycle

  • Taking corrective and preventive action when the imported product is not in compliance with US requirements.

The document is part of a broader strategic framework initiated by a multi-agency working group titled “Action Plan for Import Safety: A Roadmap for Continual Improvement.” The draft guidance can be viewed here.

Recent Videos
Miguel Forte from ISCT and Kiji Therapeutics talks about the potential impact of a changing European political landscape.
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.
Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Mike Baird from Schlafender Haser discusses industry trends from 2024 and those expected to have an impact in 2025 from the perspective of a software developer.
Preeya Beczek from Beczek.COM gives her thoughts on the areas to watch with the new US administration and how Europe might be finalizing preparations for previous legislative changes